Accordingly, the role of sUA was confirmed using an in vitro assay in which we demonstrated that sUA stimulated the dose- and time-dependent production of inflammasome-related molecules in the presence of Nlrp3 and Myd88. We confirmed our results using a model of renal disease in which we observed increased levels of sUA in the absence of crystals. Here, MYD88 is linked to kidney disorder.